Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
In patients with Duchenne Muscular Dystrophy who have an exon 51 mutation, do you treat with both prednisone and Eteplirsen?
What are common side effects to look out for with Eteplirsen?
Related Questions
In which clinical scenarios do you find medial and lateral plantar sensory or mixed nerve conduction studies to be valuable?
How do you counsel patients with mild congenital myopathy about exercise limitations?
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
Do you find IVIG to be an effective maintenance therapy for myasthenia gravis?
What is the role of skin biopsy for evaluating small fiber neuropathy in patients with rheumatic disease who have treatment recalcitrant pain?
Do you perform EMG and repetitive nerve stimulation in patients with ocular myasthenia gravis, particularly those who are AChR-positive, to assess for electrophysiological evidence of generalized disease?
How do you treat fatigue symptoms in myasthenia gravis?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
Would you recommend muscle or nerve biopsy in a patient with amyoplasia congenita?
How do you approach sequentially tapering combination therapy (i.e., IVIG, mycophenolate, rituximab) for dermatomyositis that is in remission?